abstract |
Disclosed is a pharmaceutical composition that can be easily used as a therapeutic agent for CFTR-mediated diseases such as cystic fibrosis as a modulator of CFTR activity. 3- (6- (1- (2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamide)-, characterized as compound 1 HCl salt Form A Solid form compound of 3-methylpyridin-2-yl) benzoic acid (Compound 1). [Selection figure] None |